temozolomide,olaparib
astrazeneca,merck
['sclc', 'olaparib', 'temozolomide']
#asco22 | poster 192 | mon 8:00am cdt
phase i/ii investigator-initiated study of olaparib and temozolomide in sclc: updated analysis and cns outcomes.
presenter: catherine meador, md, phd ( ) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.